⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11796900 | 0.78 | — | — | |
| SCHEMBL17266188 | 0.75 | — | — | |
| SCHEMBL28355392 | 0.73 | POLB (0.39) | — | |
| SCHEMBL2232800 | 0.69 | — | — | |
| SCHEMBL9507987 | 0.69 | MEN1 (0.33) | — | |
| SCHEMBL21064390 | 0.69 | — | — | |
| SCHEMBL28352198 | 0.67 | — | — | |
| Potassium Ion SCHEMBL15732766 | 0.67 | — | — | |
| SCHEMBL3204309 | 0.65 | — | — | |
| SCHEMBL10653217 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3311843-A1 | COMPOSITIONS COMPRISING DITHIOCARBAMATE AND CYCLODEXTRIN | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts (DE) | 2018-04-25 | — | — | EP | claimed |
| US-20140220152-A1 | Compositions and Methods for Detecting, Treating, or Preventing Reductive Stress | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2014-08-07 | — | — | US | claimed |
| US-20070232692-A1 | Method of Treating Cancer Using Dithiocarbamate Derivatives | THE UNIVERSITY OF UTAH | 2007-10-04 | — | — | US | claimed |
| US-12616995-B2 | Methods for producing overt security features exhibiting one or more indicia | SICPA HOLDING SA (CH) | 2026-05-05 | — | — | US | disclosed |
| EP-4433547-B1 | METHODS FOR PRODUCING OVERT SECURITY FEATURES EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2025-12-24 | — | — | EP | disclosed |
| US-20250121405-A1 | METHODS FOR PRODUCING OVERT SECURITY FEATURES EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2025-04-17 | — | — | US | disclosed |
| US-12215242-B2 | UV-VIS radiation curable security inks for producing dichroic security features | SICPA HOLDING SA (CH) | 2025-02-04 | — | — | US | disclosed |
| EP-4244297-B1 | UV-VIS RADIATION CURABLE SECURITY INKS FOR PRODUCING DICHROIC SECURITY FEATURES | SICPA HOLDING SA (CH) | 2024-10-09 | — | — | EP | disclosed |
| EP-4433547-A1 | METHODS FOR PRODUCING OVERT SECURITY FEATURES EXHIBITING ONE OR MORE INDICIA | Sicpa Holding SA (CH) | 2024-09-25 | — | — | EP | disclosed |
| US-20240018378-A1 | UV-VIS RADIATION CURABLE SECURITY INKS FOR PRODUCING DICHROIC SECURITY FEATURES | SICPA HOLDING SA (CH) | 2024-01-18 | — | — | US | disclosed |
| EP-4244297-A1 | UV-VIS RADIATION CURABLE SECURITY INKS FOR PRODUCING DICHROIC SECURITY FEATURES | Sicpa Holding SA (CH) | 2023-09-20 | — | — | EP | disclosed |
| US-20030229064-A1 | Method of treating cancer using dithiocarbamate derivatives | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY D/B/A CAROLINAS MEDICAL CENTER | 2003-12-11 | — | — | US | disclosed |
| EP-1328267-A2 | METHOD OF TREATING CANCER USING DITHIOCARBAMATE DERIVATIVES | Charlotte-Mecklenburg Hospital Authority doing business as Carolinas Medical Center (US) | 2003-07-23 | — | — | EP | disclosed |
| US-6589987-B2 | Dithiocarbamate, particularly tetraethylthiuram disulfide strongly inhibits the growth of cancer cells of a variety of cell types. Such inhibitory effect is enhanced by heavy metal ions such as copper ions, cytokines and ceruloplasmin and | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY | 2003-07-08 | — | — | US | disclosed |
| US-6548540-B2 | Administering dithiocarbamate thiolate anions to sensitize humans to conventional chemotherapy by blocking the p-glycoprotein membrane toxin extrusion pump | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY | 2003-04-15 | — | — | US | disclosed |
| US-20030065026-A1 | METHOD OF TREATING CANCER USING TETRAETHYL THIURAM DISULFIDE | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2003-04-03 | — | — | US | disclosed |
| EP-1214063-A1 | METHOD OF TREATING CANCER USING TETRAETHYL THIURAM DISULFIDE | Charlotte-Mecklenburg Hospital Authority doing business as Carolinas Medical Center (US) | 2002-06-19 | — | — | EP | disclosed |
| WO-2002028349-A2 | METHOD OF TREATING CANCER USING DITHIOCARBAMATE DERIVATIVES | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, DOING BUSINESS AS CAROLINAS MEDICAL CENTER (US) | 2002-04-11 | — | — | WO | disclosed |
| US-20010016600-A1 | Method of treating cancer using dithiocarbamate derivatives | THE UNIVERSITY OF UTAH | 2001-08-23 | — | — | US | disclosed |
| WO-2001017522-A1 | METHOD OF TREATING CANCER USING TETRAETHYL THIURAM DISULFIDE | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY DOING BUSINESS AS CAROLINAS MEDICAL CENTER (US) | 2001-03-15 | — | — | WO | disclosed |